RUNX1 and acute myeloid leukemia: C-MYC overexpression was detected in 13 AML patients; 4 of whom were carriers of the FLT3-ITD mutation and the remaining 9 patients were carriers of other mutations (AML1-ETO or CBFβ-MYH11) or had normal karyotype.